Milestones of Adjustment Post-Psychosis
NCT01192594 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2016-09-08
Summary
This nested design clinical outcome study of psychiatric case manager education on disease state, psychopharmacology of schizophrenia, relapse, motivational interviewing, and the process of psychological adjustment post-psychosis (Milestones of Adjustment Post-Psychosis Recovery Model-MAPP) will test the following hypotheses:
1. Medication non-adherence in patients with schizophrenia assigned to case managers who receive MAPP training will decrease from their pre-study rate and from the reported national average after one year enrollment compared to consumers not enrolled in the MAPP arm of the study.
2. Consumers in the MAPP intervention will have higher Quality of Life Enjoyment and Satisfaction Questionnaire (Q-Les-Q (53) scores than consumers not enrolled in the MAPP at quarterly measures.
3. Consumers enrolled in the MAPP intervention arm of the study will successfully complete the first two phases of the MAPP Recovery Model in one year.
4. Consumers in the MAPP intervention arm will have greater symptom reductions at quarterly data points compared to consumers not enrolled in the MAPP intervention arm.
Conditions
- Schizophrenia
- Quality of Life
- Adjustment, Psychological
- Medication Adherence
- Signs and Symptoms
Interventions
- BEHAVIORAL
-
Training in all modules including MAPP Recovery Model
50% of the case managers will complete all five modules: Disease state,psychopharmacology,symptom management, motivational interviewing and adherence, and the Milestones of Adjustment Post-Psychosis Recovery Model including the MAPP treatment guide.
- BEHAVIORAL
-
Training in all modules except MAPP Recovery Model
50% of the case managers in the study will complete only four training modules: Disease state, psychopharmacology, symptom management, and motivational interviewing and adherence. They will not complete the Milestones of Adjustment Post-Psychosis Recovery Model module.
Sponsors & Collaborators
-
Yale University
lead OTHER
Principal Investigators
-
Mary D Moller, DNP · Yale University School of Nursing
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- United States
Study Locations
More Related Trials
-
Motivation Skills Training for Schizophrenia
NCT05746455 ·Status: COMPLETED ·Phase: NA
-
Enhancing the Outcome of Skills Training for People With Schizophrenia
NCT00069433 ·Status: COMPLETED ·Phase: NA
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
A Study of Strategies to Improve Schizophrenia Treatment
NCT00156637 ·Status: COMPLETED ·Phase: NA
-
Reducing the Weight of Overweight Schizophrenia Patients
NCT00158366 ·Status: COMPLETED ·Phase: NA
-
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
NCT06197048 ·Status: RECRUITING ·Phase: NA
-
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718 ·Status: COMPLETED ·Phase: NA
-
The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
NCT07144592 ·Status: RECRUITING ·Phase: NA
-
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia
NCT02775864 ·Status: COMPLETED
-
Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia
NCT00312949 ·Status: COMPLETED ·Phase: NA
-
Evaluation the Impact of Self-Stigma Reduction Program on Psychosocial Outcomes Among People Diagnosed With Schizophrenia
NCT04087954 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis
NCT00655239 ·Status: COMPLETED ·Phase: NA
-
Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia
NCT00455663 ·Status: COMPLETED ·Phase: NA
-
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
NCT00932529 ·Status: COMPLETED ·Phase: PHASE4
-
Patient-Centered Medication Adherence Intervention for Schizophrenia
NCT00144027 ·Status: COMPLETED ·Phase: NA
-
Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia
NCT00391677 ·Status: COMPLETED ·Phase: NA
-
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
NCT00463346 ·Status: COMPLETED ·Phase: PHASE3
-
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
NCT00791440 ·Status: COMPLETED ·Phase: NA
-
Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia
NCT01433094 ·Status: COMPLETED ·Phase: NA
-
Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)
NCT00119574 ·Status: COMPLETED ·Phase: NA
-
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
NCT01016145 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
NCT00654576 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Interventional Programs' Impact on Patients' Quality of Life and Functioning
NCT06715553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
NCT00861003 ·Status: UNKNOWN